Positive results in early trials of herpes vaccine

Genital herpes is a sexually transmitted disease (STD) for which there is no known cure. People who contract this condition can expect to experience outbreaks of sores on their body, which can be spread to partners. The best way to avoid developing this infection is to practice safe sex and maintain an open dialogue with partners before engaging in sexual activity.

Recently, there have been advancements made in the development of a vaccine to treat the STD. Clinical trials have shown positive results for HerpV, which is the most advanced vaccine currently being tested to fight against herpes outbreaks.

"We are very encouraged by these clinical results as published literature suggest that cellular immunity needs to be stimulated for successful treatment of genital herpes - a physically painful and emotionally debilitating disease that affects one in six adults in the US," {space} said study author Anna Wald, M.D, M.P.H,.professor of medicine, epidemiology and laboratory medicine at the University of Washington.

Due to the high prevalence of this STD, it is important that researchers continue their efforts to find effective treatment methods against it. Hopefully, further studies will lead to the release of this or other vaccines that can prevent herpes.